Cargando…

Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered

OBJECTIVE: This study compared the dynamic susceptibility contrast (DSC) magnetic resonance imaging parameters and apparent diffusion coefficient (ADC) between pilocytic astrocytoma (PA) and diffuse midline glioma, H3K27-altered (DMG) variants. METHODS: The normalized relative cerebral blood volume...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurokawa, Ryo, Kurokawa, Mariko, Baba, Akira, Kim, John, Srinivasan, Ashok, Moritani, Toshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348548/ https://www.ncbi.nlm.nih.gov/pubmed/37450487 http://dx.doi.org/10.1371/journal.pone.0288412

Ejemplares similares

Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI
por: Kurokawa, Ryo, et al.
Publicado: (2022)

Perfusion and diffusion-weighted imaging parameters: Comparison between pre- and postbiopsy MRI for high-grade glioma
por: Kurokawa, Ryo, et al.
Publicado: (2022)

Skull metastases and osseous venous malformations: The role of diffusion‐weighted and dynamic contrast‐enhanced MRI
por: Kurokawa, Ryo, et al.
Publicado: (2022)

Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma
por: Hochart, Audrey, et al.
Publicado: (2015)

Adult Diffuse Astrocytoma in the Medulla Oblongata: Molecular Biological Analyses Including H3F3A Mutation of Histone H3.3
por: Uekawa, Ken, et al.
Publicado: (2015)

Diagnostic accuracy of diffusion weighted imaging for differentiation of supratentorial pilocytic astrocytoma and pleomorphic xanthoastrocytoma
por: She, Dejun, et al.
Publicado: (2018)

Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation
por: Orillac, Cordelia, et al.
Publicado: (2016)

The in vivo Interaction Landscape of Histones H3.1 and H3.3
por: Siddaway, Robert, et al.
Publicado: (2022)

Diffuse Spinal Leptomeningeal Spread of a Pilocytic Astrocytoma in a 3-year-old Child
por: Alyeldien, Ameer, et al.
Publicado: (2016)

IMMU-31. PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M DIFFUSE MIDLINE GLIOMAS (DMG)
por: Mueller, Sabine, et al.
Publicado: (2020)

The CENP-T C-Terminus Is Exclusively Proximal to H3.1 and not to H3.2 or H3.3
por: Abendroth, Christian, et al.
Publicado: (2015)

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
por: Zhao, Ji-ping, et al.
Publicado: (2022)

Diffusion differences between pilocytic astrocytomas and grade II ependymomas
por: Pavlisa, Goran, et al.
Publicado: (2011)

The role of diffusion and perfusion magnetic resonance imaging in differentiation of haemangioblastomas and pilocytic astrocytomas
por: Neska-Matuszewska, Małgorzata, et al.
Publicado: (2018)

H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma
por: Immisch, Lena, et al.
Publicado: (2022)

Diffuse leptomeningeal spread of supratentorial recurrent pilocytic astrocytoma in a child
por: Raheja, Amol, et al.
Publicado: (2015)

INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas
por: Grassl, Niklas, et al.
Publicado: (2023)

HGG-33. Prognostic factors of H3K27M histone-mutant diffuse midline gliomas in patients ≤18yrs
por: Hu, Qingjun, et al.
Publicado: (2022)

Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours
por: Métais, Alice, et al.
Publicado: (2022)

THER-05. GENETICALLY STABLE POLIOVIRUS VECTOR CARRYING H3.3K27M ANTIGEN FOR TREATMENT OF DIFFUSE MIDLINE GLIOMA BY INTRAMUSCULAR INJECTION
por: Mosaheb, Mubeen, et al.
Publicado: (2020)

Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma
por: Wang, Stacie S., et al.
Publicado: (2023)

H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant
por: Maeda, Sachi, et al.
Publicado: (2020)

Fatal Postpartum Hemorrhage in Diffuse Midline Glioma with H3-K27M Mutation
por: Miyazaki, Takeshi, et al.
Publicado: (2019)

DIPG-42. Diffuse midline gliomas, H3K27-altered as an interdisciplinary challenge
por: Kammler, Gertrud, et al.
Publicado: (2022)

Radiotherapy and radio‐sensitization in H3 (K27M) ‐mutated diffuse midline gliomas
por: Liu, Chao, et al.
Publicado: (2023)

A H3K27M-targeted vaccine in adults with diffuse midline glioma
por: Grassl, Niklas, et al.
Publicado: (2023)

Neuroimaging of a pilocytic astrocytoma with anaplastic features and diffusion tensor imaging characteristics
por: Walkoff, Lara, et al.
Publicado: (2015)

H3.3S31 phosphorylation: linking transcription elongation to stimulation responses
por: Wen, Hong, et al.
Publicado: (2020)

STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma
por: Anderson, Jacob B., et al.
Publicado: (2023)

HGG-31. Unique case of a bithalamic H3K27-wildtype diffuse midline glioma, EGFR-altered with methylated MGMT
por: Reinecke, James, et al.
Publicado: (2022)

Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatars
por: Skinner, Kasey R., et al.
Publicado: (2023)

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
por: Banan, Rouzbeh, et al.
Publicado: (2017)

Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas
por: Welby, John P., et al.
Publicado: (2019)

Morphological Spectrum and Survival Analysis of Diffuse Midline Glioma With H3K27M Mutation
por: Hassan, Usman, et al.
Publicado: (2021)

Diffuse midline glioma H3K27M mutation in adult: A case report
por: Bhattarai, Ayush Mohan, et al.
Publicado: (2022)

Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman
por: Low, Justin Thomas, et al.
Publicado: (2021)

HGG-45. Characterization of spinal diffuse midline gliomas, H3 K28M-mutant
por: Stegat, Lotte, et al.
Publicado: (2022)

Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration
por: Huang, Bowen, et al.
Publicado: (2023)

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
por: Jackson, Evangeline R., et al.
Publicado: (2023)

Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones
por: Sarthy, Jay F, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_diftc1sunb1oo66tv24lskc3cc